STOCK TITAN

Medbright AI Stock Price, News & Analysis

MBAIF OTC

Welcome to our dedicated page for Medbright AI news (Ticker: MBAIF), a resource for investors and traders seeking the latest updates and insights on Medbright AI stock.

MedBright AI Investments Inc. (MBAIF) issues frequent updates that highlight its activities as a capital allocator in healthcare technology and artificial intelligence. News about the company often centers on its portfolio investments, commercialization milestones for AI platforms, and corporate developments in leadership and strategy. For investors and observers, this news flow provides insight into how MedBright AI is building and managing its portfolio of AI-driven healthcare and technology assets.

One recurring theme in MedBright AI’s news is the progress of MedMatrix, a product in which it has a significant investment. The company has reported MedMatrix’s transition from beta testing to full commercialization, the launch of a five-feature AI product suite for outpatient clinics, and the announcement of go-to-market pricing. Additional news has covered commercial traction, such as a multi-year contract with a dermatology clinic in Southern California and new product demonstration videos for the MedMatrix AI Reporter and Forecaster tools.

Another important news topic is Limmi’s Disease Insights Platform, a key investment in MedBright AI’s AI healthcare portfolio. The company has announced that Limmi’s platform is being used in a university hospital setting with an initial focus on kidney stone disease recurrence, illustrating how its portfolio companies are applying AI to complex health data and clinical research questions.

MedBright AI’s news also covers strategic investments and corporate actions. The company has disclosed a strategic investment into Algo8 Industrial AI Inc., described as a global pioneer in industrial AI, and has reported on leadership changes, including the appointment of a Chief Executive Officer and a new director with extensive capital markets and operating experience. Earlier, MedBright AI announced a letter of intent for a proposed acquisition by Numinus Wellness Inc., followed by a later announcement that the letter of intent was terminated.

By following MedBright AI news, readers can track developments in its healthcare and industrial AI investments, commercialization steps for platforms like MedMatrix and Limmi, and ongoing changes in the company’s governance and strategic direction.

Rhea-AI Summary

CIBT Education Group Inc. (TSX:MBA)(OTCQX:MBAIF) has provided an update on its Atmosphere Project in Richmond, B.C., where its subsidiary, Global Education City (Richmond) Limited Partnership, has encountered financial challenges. On April 1, 2022, the project developer initiated a Companies' Creditors Arrangement Act proceeding to reorganize financially. CIBT is exploring options to increase investment in the project and partner with a local developer for restructuring, citing opportunities in Vancouver's real estate market. The next hearing is scheduled for April 25, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

CIBT Education Group Inc. (TSX:MBA)(OTCQX International:MBAIF) announced approval for a normal course issuer bid (NCIB) to repurchase up to 3,423,000 common shares, equating to about 5% of its outstanding shares. The maximum acquisition cost is approximately $3,000,000. The buyback is driven by the belief that recent market prices do not reflect the company's value and prospects. Purchases will occur over a 12-month period starting March 21, 2022. CIBT previously bought back 2,734,500 shares at an average price of $0.70685507.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Rhea-AI Summary

CIBT Education Group Inc. (TSX:MBA)(OTCQX:MBAIF) has received approval from the Toronto Stock Exchange for a normal course issuer bid (NCIB) to repurchase up to 3,423,000 common shares at a maximum cost of $3,000,000. This represents approximately 4.999% of its issued shares as of March 16, 2022. The NCIB is set to run from March 21, 2022 to March 20, 2023, with the aim of enhancing shareholder value amidst current market prices perceived as undervaluing the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-100%
Tags
none
Rhea-AI Summary

CIBT Education Group Inc. (MBAIF) announced the results of its recent annual general meeting, where all nominated directors were successfully elected. Key voting results include:

  • Morris Chen: 99.73% in favor
  • Toby Chu: 91.57% in favor
  • Tony David: 99.41% in favor
  • Derek Feng: 99.41% in favor
  • May Hsu: 99.41% in favor
  • Troy Rice: 99.41% in favor
  • Shane Weir: 99.43% in favor
Additionally, CIBT continues to focus on education and student housing, offering over 150 programs and serving over 10,000 students annually.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

CIBT Education Group Inc. (MBAIF) reported strong financial performance for Q1 F2022, with total revenues reaching $17.07 million, marking a 19% increase compared to the previous year. Notably, educational revenues from Sprott Shaw College surged by 8% while international college revenues skyrocketed 209%. Rental revenues also rose by 145%, contributing to overall EBITDA growth of 16%. Despite a slight decrease in net income attributable to shareholders, the company maintains a solid balance sheet with total assets up 1% to $526.43 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.52%
Tags
-
Rhea-AI Summary

CIBT Education Group (TSX:MBA)(OTCQX:MBAIF) reported its annual financial results for fiscal year ended August 31, 2021, with total revenues at $60.87 million, marking a 3% decline from the prior year. However, net income surged 209% to $5.18 million, while net income attributable to shareholders climbed 283% to $4.7 million. The income per share rose 250% to $0.07. The company successfully raised over $8.4 million in equity and completed $171 million in financing, amidst ongoing pandemic challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-100%
Tags
Rhea-AI Summary

CIBT Education Group has reported significant advancements in its education services following the post-pandemic economy's reopening. The company has launched new programs, including Dental Assistant and Cybersecurity, complementing its existing 130 programs. In fiscal 2021, it achieved a 24.5% increase in student registrations and a 30% rise in tuition revenue. The international education sector is recovering, with strong demand expected for English as a Second Language (ESL) courses. Additionally, CIBT has committed $500,000 in scholarships to support vulnerable youth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.21%
Tags
none
-
Rhea-AI Summary

CIBT Education Group (TSX:MBA)(OTCQX:MBAIF) has reported positive trends in its academic assets and real estate investments. Enrollments at Sprott Shaw College are rising as Canada opens its borders to international students. GEC Education Mega Center has received rezoning approval, with a $300 million budget. Occupancy rates for GEC properties are at 90-100%, and rental rates have returned to pre-COVID levels. The company is negotiating multiple real estate transactions and plans to develop over 1.14 million square feet in fiscal 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.9%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

CIBT Education Group (TSX:MBA)(OTCQX:MBAIF) announced its flagship project, GEC Education Mega Center, was featured in The Globe and Mail. This recognition enhances the company’s visibility in the education sector. CIBT, operating since 1994, manages a real estate portfolio exceeding $1.5 billion and provides services to over 11,000 students annually through its various educational subsidiaries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.78%
Tags
none

FAQ

What is the current stock price of Medbright AI (MBAIF)?

The current stock price of Medbright AI (MBAIF) is $0.085 as of January 2, 2026.

What is the market cap of Medbright AI (MBAIF)?

The market cap of Medbright AI (MBAIF) is approximately 8.0M.